HIV & AIDS

Global AIDS fight at crossroads after setbacks during COVID

Hard-won progress against HIV has stalled, putting millions of lives at risk, according to an alarming report Wednesday on how the COVID-19 pandemic and other global crises are jeopardizing efforts to end AIDS.

Medical research

Artificial intelligence in the fight against river blindness

More than 21 million people in Africa are infected with the nematode Onchocerca volvulus, the cause of river blindness. Around one in ten of those affected goes blind. Parasitologists at the University Hospital Bonn are looking ...

Psychology & Psychiatry

Common antibiotic may help to prevent or treat PTSD

The common antibiotic doxycycline can disrupt the formation of negative associations in the brain, according to new research from UCL and the University of Zurich.

Neuroscience

Gene therapy for hearing loss: Potential and limitations

Regenerating sensory hair cells, which produce electrical signals in response to vibrations within the inner ear, could form the basis for treating age- or trauma-related hearing loss. One way to do this could be with gene ...

page 1 from 4

Doxycycline

Doxycycline INN ( /ˌdɒksɨˈsaɪkliːn/ doks-i-sy-kleen) is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. Doxycycline is a semisynthetic tetracycline invented and clinically developed in the early 1960s by Pfizer Inc.[citation needed] and marketed under the brand name Vibramycin.[citation needed] Vibramycin received U.S. Food and Drug Administration (FDA) approval in 1967,[citation needed] becoming Pfizer's first once-a-day, broad-spectrum antibiotic.[citation needed] Other brand names include Monodox, Microdox, Periostat, Vibra-Tabs, Oracea, Doryx, Vibrox, Adoxa, Doxyhexal, Doxylin, Doxoral,Doxy-1 and Atridox (topical doxycycline hyclate for periodontitis).

This text uses material from Wikipedia, licensed under CC BY-SA